We invest in transformative healthcare technologies that can significantly improve patient outcomes or streamline healthcare delivery. Specifically, we invest in medical devices, diagnostics and digital health. We invest in growth stage, commercially ready companies that are either already on the market or have a predictable path towards market entry. Where relevant, a regulatory approval should have been secured in one or more geographies.
Although we traditionally invest in later-stage companies, we are happy to review and track earlier stage opportunities to develop a relationship and invest when the time is right.